Modalities of G-CSF Zarzio® use in clinical practice in patients receiving cytotoxic chemotherapy regimens in which the rest period does not exceed 14 days for breast, lung, gastrointestinal cancers and lymphoma. (TOPAZE) First published 02/11/2015 Last updated 28/04/2025 EU PAS number:EUPAS11465 Study Ongoing